Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B

Journal of Virology

Volumn 75, Issue 16, 2001, Pages 7494-7505

  Tsunoda, I ^a   Wada, Y ^a   Libbey, J E ^a   Cannon, T S ^a   Whitby, F G ^a   Fujinami, R S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GRAY MATTER; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS ENCEPHALITIS; VIRUS MUTANT; VIRUS REPLICATION; VIRUS STRAIN; WHITE MATTER;

AMINO ACID SEQUENCE; ANIMALS; CAPSID; CAPSID PROTEINS; CEREBRAL CORTEX; DEMYELINATING DISEASES; MICE; MOLECULAR SEQUENCE DATA; MUTATION; THEILOVIRUS; VIRULENCE;

EID: 0034898075     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.16.7494-7505.2001     Document Type: Article

References (53)

1. A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses
2. Multiple sclerosis
3. Follicular dendritic cells (FDC) in retroviral infection: Host/pathogen perspectives
4. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelination: A model for human multiple sclerosis
5. Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system
6. Strains from both Theiler's virus subgroups encode a determinant for demyelination
7. Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus twenty-six infection by passive administration of neutralizing monoclonal antibody
8. Neutralization of Theiler's virus
9. + T cell line specific for an immunodominant VP2 epitope
10. Three-dimensional structure of Theiler virus
11. Antibody-dependent enhancement of infection: A mechanism for indirect virus entry into cells
12. Follicular dendritic cells and human immunodeficiency virus infectivity
13. Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus
14. Molecular determinants of Theiler's murine encephalomyelitis-induced disease
15. A single amino acid change determines persistence of a chimeric Theiler's virus
16. Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system
17. Adaptation of Theiler's virus to L929 cells: Mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence
18. Protection of SJL/J mice from demyelinating disease mediated by Theiler's murine encephalomyelitis virus
19. Antibody-mediated clearance of alphavirus infection from neurons
20. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature
21. Molecular characterization of a nondemyelinating variant of Daniel's strain of Theiler's virus isolated from a persistently infected glioma cell line
22. Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size
23. Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain)
24. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GD-VII) and implications for determinants of viral persistence
25. Reversibility of the reaction between poliovirus and neutralizing antibody of rabbit origin
26. Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis
27. Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus
28. Specific infection and destruction of dopaminergic neurons in the substantia nigra by Theiler's virus
29. Three-dimensional model of the capsid proteins of two biologically different Theiler virus strains: Clustering of amino acid difference identifies possible locations of immunogenic sites on the virion
30. Chronic Theiler's virus infection in mice: Appearance of myelin basic protein in the cerebrospinal fluid and serum antibody directed against MBP
31. Theiler's murine encephalomyelitis: A model of demyelination and persistence of virus
32. Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GD-VII/DA viruses
33. Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus
34. Conservation of the putative receptor attachment site in picornaviruses
35. Immunopathogenesis of dengue hemorrhagic fever
36. A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype
37. Human immunodeficiency virus. Trapped but still dangerous
38. The growth of four human and animal enteroviruses in the central nervous systems of mice
39. The course of disease and persistence of virus in the central nervous system varies between individual CBA mice infected with the BeAn strain of Theiler's murine encephalomyelitis virus
40. DNA vaccination against Theiler's murine encephalomytlitis virus leads to alterations in demyelinating disease
41. Two models for multiple sclerosis: Experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus
42. Theiler's murine encephalomyelitis virus
43. A comparative study of acute and chronic diseases induced by two subgroups of Theiler's murine encephalomyelitis virus
44. Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA
45. Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus
46. Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant
47. Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA
48. Viral infection and dissemination through the olfactory pathway and the limbic system by Theiler's virus
49. Replacement of loop II of VP-1 of the DA strain with loop II of the GDVII strain of Theiler's murine encephalomyelitis virus alters neurovirulence, viral persistence and demyelination
50. Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease
51. Role of sialyloligosaccharide binding in Theiler's virus persistence
52. Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus
53. Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection